1. Home
  2. COUR vs MPLT Comparison

COUR vs MPLT Comparison

Compare COUR & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coursera Inc.

COUR

Coursera Inc.

HOLD

Current Price

$5.80

Market Cap

1.5B

Sector

Technology

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

N/A

Current Price

$13.77

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COUR
MPLT
Founded
2012
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
COUR
MPLT
Price
$5.80
$13.77
Analyst Decision
Buy
Strong Buy
Analyst Count
15
7
Target Price
$10.53
$32.67
AVG Volume (30 Days)
4.0M
553.7K
Earning Date
04-23-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
39.22
82.39
EPS
N/A
N/A
Revenue
$757,500,000.00
N/A
Revenue This Year
$9.43
N/A
Revenue Next Year
$6.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.04
N/A
52 Week Low
$5.00
$9.10
52 Week High
$12.32
$40.43

Technical Indicators

Market Signals
Indicator
COUR
MPLT
Relative Strength Index (RSI) 53.62 39.67
Support Level $5.12 $12.24
Resistance Level $6.34 $20.20
Average True Range (ATR) 0.26 0.94
MACD 0.01 0.89
Stochastic Oscillator 52.04 74.93

Price Performance

Historical Comparison
COUR
MPLT

About COUR Coursera Inc.

Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: